The U.S. Food and Drug Administration (FDA) is alerting health care providers about import alerts for certain medical devices manufactured in Japan by Olympus Medical Systems Corporation (Olympus) and its subsidiaries.
Similar Posts
Biosimilars Research: Awards
Biosimilars Research: AwardsAbout CDER Small Business and Industry Assistance (SBIA)
CDER Small Business and Industry Assistance (SBIA) helps small pharmaceutical business and industry navigate the wealth of information that FDA offers, and provides assistance in understanding the regulation of human drug products.Kenz Henz Recalls “Pastured Raised Eggs” Because of Possible Health Risk
Kenz Henz of Santa Fe, TX, is recalling its 12 count packages of “Grade AA Large Pasture Raised eggs” because they have the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weaCondition-Specific Meeting Reports and Other Information Related to Patients’ Experience
This webpage provides links to certain publicly available external reports and resources relating to patient experience data. The patient community, patient advocates, researchers, drug developers, and federal agencies may find these materials useful.The Center for Research on Complex Generics
FDA awards a 5-year grant to the University of Maryland and the University of Michigan to establish a Center for Research on Complex Generics (CRCG).Miers Laboratories, Ltd – 715378 – 11/03/2025
CGMP/Finished Pharmaceuticals/Adulterated